Market Overview

Why Novavax's Stock Is Trading Higher Today

Why Novavax's Stock Is Trading Higher Today

Novavax (NASDAQ: NVAX) shares are trading higher on Friday after Cantor Fitzgerald raised its price target on the stock from $45 to $88.

The stock has regained investor interest amid a resurgence in coronavirus cases, as the company is working on a vaccine candidate.

Novavax is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases.

Novavax shares were trading up 6.55% at $63.15 at time of publication on Friday. The stock has a 52-week high of $64.32 and a 52-week low of $3.54.

Latest Ratings for NVAX

Dec 2020JefferiesInitiates Coverage OnBuy
Nov 2020HC Wainwright & Co.MaintainsBuy
Aug 2020HC Wainwright & Co.MaintainsBuy

View More Analyst Ratings for NVAX
View the Latest Analyst Ratings


Related Articles (NVAX)

View Comments and Join the Discussion!

Posted-In: why it's movingPrice Target Analyst Ratings

Latest Ratings

DEBMO CapitalMaintains400.0
PRITruist SecuritiesMaintains165.0
SHAKJP MorganMaintains70.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at